{"id":37437,"date":"2025-09-16T17:45:00","date_gmt":"2025-09-16T15:45:00","guid":{"rendered":"https:\/\/www.transgene.com\/?p=37437"},"modified":"2026-07-09T13:28:57","modified_gmt":"2026-07-09T11:28:57","slug":"donnees-positives-de-la-phase-i-randomisee-de-tg4050-vaccin-therapeutique-individualise-neoantigenique-contre-le-cancer-fin-de-la-randomisation-de-la-partie-phase-ii-au-quatrieme-trimestre-2025","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/donnees-positives-de-la-phase-i-randomisee-de-tg4050-vaccin-therapeutique-individualise-neoantigenique-contre-le-cancer-fin-de-la-randomisation-de-la-partie-phase-ii-au-quatrieme-trimestre-2025\/","title":{"rendered":"Donn\u00e9es positives de la Phase I randomis\u00e9e de TG4050, vaccin th\u00e9rapeutique individualis\u00e9 n\u00e9oantig\u00e9nique contre le cancer &#8211; Fin de la randomisation de la partie Phase II au quatri\u00e8me trimestre 2025"},"content":{"rendered":"\n<hr class=\"wp-block-separator has-alpha-channel-opacity eplus-wrapper\"\/>\n\n\n\n<p class=\"eplus-wrapper wp-block-paragraph\"><a id=\"_msocom_1\"><\/a><\/p>\n\n\n\n<p class=\"eplus-wrapper wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"eplus-wrapper wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"eplus-wrapper wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"eplus-wrapper wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"eplus-DVrMbh\"><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20250916_Transgene_2025_Resultats-Financiers-Semestriels_FR.pdf\">H1 resultats financiers<\/a><\/p>\n\n\n\n\n","protected":false},"excerpt":{"rendered":"<p>H1 resultats financiers<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[174,11,71,80],"tags":[],"class_list":["post-37437","post","type-post","status-publish","format-standard","hentry","category-174","category-press-release-fr","category-myvac-fr","category-tg4050-fr","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"H1 resultats financiers","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/37437","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=37437"}],"version-history":[{"count":3,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/37437\/revisions"}],"predecessor-version":[{"id":41397,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/37437\/revisions\/41397"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=37437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=37437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=37437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}